Serum and Soleus Metabolomics Signature of Klf10 Knockout Mice to Identify Potential Biomarkers
Authors:
- Nadine BaroukhNBNadine Baroukh
- Nathan CanteleuxNCNathan Canteleux
- Antoine LefèvreALAntoine Lefèvre
- Camille DupuyCDCamille Dupuy
- Cécile MartiasCMCécile Martias
- Antoine PressetAPAntoine Presset
- Malayannan SubramaniamMSMalayannan Subramaniam
- John R. HawseJohn R. Hawse
- Patrick EmondPEPatrick Emond
- Philippe PouletautPPPhilippe Pouletaut
- Sandrine MorandatSMSandrine Morandat
- Sabine F. BensamounSBSabine F. Bensamoun
Open Access
- 17 June 2022
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 12 (6) , 556
Abstract
The transcription factor Krüppel-like factor 10 (Klf10), also known as Tieg1 for TGFβ (Inducible Early Gene-1) is known to control numerous genes in many cell types that are involved in various key biological processes (differentiation, proliferation, apoptosis, inflammation), including cell metabolism and human disease. In skeletal muscle, particularly in the soleus, deletion of the Klf10 gene (Klf10 KO) resulted in ultrastructure fiber disorganization and mitochondrial metabolism deficiencies, characterized by muscular hypertrophy. To determine the metabolic profile related to loss of Klf10 expression, we analyzed blood and soleus tissue using UHPLC-Mass Spectrometry. Metabolomics analyses on both serum and soleus revealed profound differences between wild-type (WT) and KO animals. Klf10 deficient mice exhibited alterations in metabolites associated with energetic metabolism. Additionally, chemical classes of aromatic and amino-acid compounds were disrupted, together with Krebs cycle intermediates, lipids and phospholipids. From variable importance in projection (VIP) analyses, the Warburg effect, citric acid cycle, gluconeogenesis and transfer of acetyl groups into mitochondria appeared to be possible pathways involved in the metabolic alterations observed in Klf10 KO mice. These studies have revealed essential roles for Klf10 in regulating multiple metabolic pathways whose alterations may underlie the observed skeletal muscle defects as well as other diseases.Keywords
Funding Information
- Idex Sorbonne University Investments for the Future programs (SU-19-3-EMRG-12, R01 DE14036)
- National Institutes of Health (SU-19-3-EMRG-12, R01 DE14036)
This publication has 59 references indexed in Scilit:
- The metabolic footprint of aging in miceScientific Reports, 2011
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Role of Krüppel-like factors in leukocyte development, function, and diseaseBlood, 2010
- Mammalian Krüppel-Like Factors in Health and DiseasesPhysiological Reviews, 2010
- Krüppel-Like Factor KLF10 Is a Link between the Circadian Clock and Metabolism in LiverMolecular and Cellular Biology, 2010
- Functional role of KLF10 in multiple disease processesBioFactors, 2010
- TIEG1-NULL OSTEOCYTES DISPLAY DEFECTS IN THEIR MORPHOLOGY, DENSITY AND SURROUNDING BONE MATRIXJournal of Musculoskeletal Research, 2009
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- TIEG-null mice display an osteopenic gender-specific phenotypeBone, 2008